TCL Archive Over Half of ALK-Positive NSCLC Patients Responded To Crizotinib In Colorado Study November 26, 2010
TCL Archive NCI, IOM Called To Congress to Explain Divergent Positions On Minority Research January 29, 1999
TCL Archive Novartis Begins Study Of Femara And Zometa In Postmenopausal Early Breast Cancer December 27, 2002